Stockscreener 앱 받기
438.10
0.39%
-1.70
시간 외 거래:
437.33
-0.77
-0.18%
전일 마감가:
$439.80
열려 있는:
$439.495
하루 거래량:
2.00M
Relative Volume:
1.02
시가총액:
$155.16B
수익:
$10.58B
순이익/손실:
$3.00B
주가수익비율:
53.14
EPS:
8.2437
순현금흐름:
$2.83B
1주 성능:
+4.03%
1개월 성능:
-9.41%
6개월 성능:
-21.99%
1년 성능:
-19.27%
1일 변동 폭
$434.77
$443.86
1주일 범위
$421.95
$449.77
52주 변동 폭
$417.74
$603.88
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-23 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-06-09 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-06-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
Intuitive Surgical, Inc. stock (US46120E6023): Da Vinci maker grows on strong procedure demand - AD HOC NEWS
Insider Sell Alert: Mark Brosius Sells Shares of Intuitive Surgi - GuruFocus
Intuitive surgical EVP Mark Brosius sells $15,945 in stock By Investing.com - Investing.com South Africa
Intuitive surgical EVP Mark Brosius sells $15,945 in stock - Investing.com
Intuitive Surgical (ISRG) EVP Brosius sells 36 shares in planned trades - Stock Titan
Intuitive readies 100 updates and improvements for da Vinci 5 - MedTech Dive
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - TradingView
3 Big Reasons ISRG Should Be On Your Watchlist - Yahoo Finance
Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors - Yahoo Finance
Are Wall Street Analysts Bullish on Intuitive Surgical Stock? - Yahoo Finance
Precision Trading with Intuitive Surgical Inc. (ISRG) Risk Zones - Stock Traders Daily
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - MarketWatch
2 Most Compelling Stocks to Buy for Long‑Term Investors Right Now - The Motley Fool
Intuitive Surgical stock (US46120E6023): insider sale and long?term growth story in focus - AD HOC NEWS
Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report? - Yahoo Finance
Intuitive Unveils Da Vinci 5 Ecosystem Enhancements - Medical Product Outsourcing
Intuitive announces da Vinci 5 updates, extended instrument use By Investing.com - Investing.com Canada
Intuitive Announces Innovations to Advance Quintuple Aim - Scott Coop
Robotic surgery gets telepresence, force-sensing tools in Intuitive upgrade - Stock Titan
ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver? - TradingView
Insider Sell: Mark Brosius Sells Shares of Intuitive Surgical In - GuruFocus
Intuitive surgical EVP Brosius sells $23,463 in company stock - Investing.com
Intuitive Surgical (NASDAQ: ISRG) EVP sells 54 shares via Rule 10b5-1 plan - Stock Titan
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical stock (US46120E6023): da Vinci maker in focus after latest earnings and analyst u - AD HOC NEWS
North America Minimally Invasive Surgery Robot Market Worth US$ - openPR.com
Investors heavily search Intuitive Surgical, Inc. (ISRG): Here is what you need to know - MSN
Silver Economy Investing: Why the Healthcare Giants Are in Focus - TradingView
Robotics expert Brian Miller on product development, AI and what he learned at Intuitive - Medical Design & Outsourcing
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader in focus after latest quarter - AD HOC NEWS
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
ISRG DCF Analysis: Intrinsic Value $196 vs Price $440 - GuruFocus
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader after latest earnings - AD HOC NEWS
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 4.5% Rally? GF Value Says Undervalued - GuruFocus
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 4.5% R - GuruFocus
Assessing Intuitive Surgical (ISRG) Valuation After The Recent Share Price Pullback - Yahoo Finance
Intuitive Surgical Price Target Cut to $520.00/Share From $650.00 by B of A Securities - Moomoo
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.76% on May 18: A Full Analysis - TradingKey
Here is what to know beyond why Intuitive Surgical, Inc. (ISRG) is a trending stock - MSN
Intuitive Surgical, Inc. Stock 12‑Month Price Target Cut to $577.87, Implies 37% Upside - TradingView
North Dakota State Investment Board Invests $6.93 Million in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring A Potential 37% Upside - DirectorsTalk Interviews
Gabelli Funds LLC Reduces Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
ISRG Technical Analysis | Trend, Signals & Chart Patterns | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
Intuitive Surgical, Inc. (ISRG) advances but underperforms market: Key facts - MSN
The Global Price of Progress: The Geography of Robotic Surgery - Yale Global Health Review
Intuitive Surgical's moat is getting stronger -- is this the closest thing to a 'forever' stock? - MSN
Intuitive Surgical: Buy Rating Reiterated on Strong Momentum and New da Vinci 5 Platform; $650 Price Target Maintained - TipRanks
Intuitive Surgical, Inc. (ISRG) rises but trails market: What investors should know - MSN
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
0.22%
자본화:
|
볼륨(24시간):